Science & Technology
Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R41HL167327-01
Award Ceiling
$306K
Award Floor
$306K
Close Date
Jan 31, 2024
Total Funding
$306K
Expected Awards
1
Posted Date
Feb 15, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R41HL167327-01
Description
STTR Phase Phase I award: "Novel Therapeutics for Heart Failure: Modified, Water-Soluble Caveolin-1 Scaffolding Domain Peptides with Improved Characteristics for Drug Development" awarded to FIBROTHERAPEUTICS INC in CHARLESTON, South Carolina. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $306,472. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.